These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 21218018)
1. Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia. Koh KN; Park M; Kim BE; Im HJ; Park CJ; Jang S; Chi HS; Seo JJ Korean J Pediatr; 2010 Nov; 53(11):957-64. PubMed ID: 21218018 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using "MRD lite" panel. Chatterjee T; Somasundaram V Med J Armed Forces India; 2017 Jan; 73(1):54-57. PubMed ID: 28123246 [TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations]. Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033 [TBL] [Abstract][Full Text] [Related]
4. [Minimal residual disease detection in acute leukemia patients by flow cytometric assay of cross-lineage antigen expression]. Cho YU; Park CJ; Cha CH; Chi HS; Jang S; Kim MJ; Lee KH; Lee JH; Lee JH; Seo JJ; Im HJ Korean J Lab Med; 2010 Dec; 30(6):533-9. PubMed ID: 21157135 [TBL] [Abstract][Full Text] [Related]
5. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry]. Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473 [TBL] [Abstract][Full Text] [Related]
6. [Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia]. Liu YR; Zhang LP; Chang Y; Cheng YF; Fu JY; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):302-5. PubMed ID: 16875577 [TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of detecting minimal residual disease in acute childhood B-cell lymphoblastic leukemia with flow cytometry]. Zhang LP; Cheng YF; Liu GL; Lu AD; Liu YR; Wang H Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):481-5. PubMed ID: 16083543 [TBL] [Abstract][Full Text] [Related]
9. [The limited possibility of using a simplified approach to detect minimal residual disease by the flow cytometry technique in children with precursor B-lineage acute lymphoblastic leukemia]. Popov AM; Verzhbitskaia T; Tsaur GA; Shorikov EV; Tsvirenko SV; Savel'ev LI; Fechina LG Klin Lab Diagn; 2011 Mar; (3):25-9. PubMed ID: 21574456 [TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. LĂșcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733 [TBL] [Abstract][Full Text] [Related]
14. [Clinical importance of minimal residual disease testing in the therapy of childhood B-cell acute lymphoblastic leukemia]. Ye QD; Gu LJ; Tang JY; Xue HL; Chen J; Pan C; Chen J; Dong L; Zhou M; Jiang LM Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):333-6. PubMed ID: 18554462 [TBL] [Abstract][Full Text] [Related]
15. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation. Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A; Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560 [TBL] [Abstract][Full Text] [Related]
16. Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study. Chowdhury S; Bandyopadhyay S; Mandal C; Chandra S; Mandal C BMC Cancer; 2008 Feb; 8():40. PubMed ID: 18241334 [TBL] [Abstract][Full Text] [Related]
17. A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Coustan-Smith E; Ribeiro RC; Stow P; Zhou Y; Pui CH; Rivera GK; Pedrosa F; Campana D Blood; 2006 Jul; 108(1):97-102. PubMed ID: 16537802 [TBL] [Abstract][Full Text] [Related]
18. [Clinical research on clearance of leukemic cell during induction of remission therapy in children with precursor B cell acute lymphoblastic leukemia]. Yi ZG; Cui L; Gao C; Jin M; Zhang RD; Li ZG; Wu MY Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):170-4. PubMed ID: 21575363 [TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia. Wang H; Zhou Y; Huang X; Zhang Y; Qian J; Li J; Li C; Li X; Lou Y; Zhu Q; Huang Y; Meng H; Yu W; Tong H; Jin J; Zhu HH Br J Haematol; 2021 Jun; 193(6):1096-1104. PubMed ID: 33764511 [TBL] [Abstract][Full Text] [Related]
20. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance]. Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]